KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

A randomized phase II study comparing preoperative mFOLFOX6 versus FOLFOXIRI for locally advanced colon cancer: JCOG2006.

Tadayoshi Hashimoto, Satoshi Maruyama, Yasumasa Takii, Junki Mizusawa, Tomoko Kataoka, Haruhiko Fukuda, Shunsuke Tsukamoto, Atsuo Takashima, Tetsuya Hamaguchi, Yukihide Kanemitsu

Future Oncol 19(28) 1897-1904

PMID37750332
PMCID-
DOI10.2217/fon-2023-0091
发表日期2023-09-26
摘要

摘要

The prognosis of locally advanced colon cancer (LACC) with surgical resection followed only by adjuvant chemotherapy is poor. Preoperative chemotherapy for LACC patients with risk factors such as cT4bN+ or cT3-4aN2-3 has attracted attention. Here, the authors describe the rationale and design of JCOG2006, a randomized phase II study comparing preoperative chemotherapy with mFOLFOX6 versus FOLFOXIRI for LACC. Their efficacy and safety are evaluated and a determination of which is the more promising treatment will be conducted in a subsequent phase III trial. A total of 86 patients will be accrued from 44 institutions over 2 years. The primary end point is the proportion of patients with a Tumor Regression Score of 0-2, and secondary end points include overall survival, response rate and adverse events. Clinical Trial Registration: jRCTs031210365 (https://jrct.niph.go.jp/).

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。